Join
Live feed
·
INSIDERFilingvia Quantisnow
Baudax Bio Inc. logo

SEC Form 4: S Richard Casten bought $35,180 worth of Common Stock (25,000 units at $1.41), increasing direct ownership by 25% to 125,000 units

ByQuantisnow·Wall Street's wire, on your screen.
BXRX· Baudax Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BXRX (Baudax Bio Inc.) and more on Quantisnow.

SEC Form 4: S Richard Casten bought $35,180 worth of Common Stock (25,000 units at $1.41), increasing direct ownership by 25% to 125,000 units | Quantisnow